Back to Search Start Over

SPRY4 inhibits and sensitizes the primary KIT mutants in gastrointestinal stromal tumors (GISTs) to imatinib

Authors :
Shujing Li
Sien Zhao
Nianhai Liang
Shaoting Zhang
Liangying Zhang
Liangji Zhou
Anbu Liu
Xu Cao
Jinhai Tian
Yuanyuan Yu
Zhaoyang Fan
Kun Xiao
Ming Wang
Hui Zhao
Ru Bai
Jianmin Sun
Source :
Gastric Cancer.
Publication Year :
2023
Publisher :
Springer Science and Business Media LLC, 2023.

Subjects

Subjects :
Cancer Research
Oncology
Gastroenterology
General Medicine

Details

ISSN :
14363305 and 14363291
Database :
OpenAIRE
Journal :
Gastric Cancer
Accession number :
edsair.doi...........b219c2b0c85ce16dbed5643060179a8c

Tools

Authors Abstract Subjects Details